Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To demonstrate the efficacy of MK-0524 to protect against niacin-induced flushing in patients who resume therapy with either MK-0524A 2g or ER-niacin 2g after a 5 day drug holiday from a stable dose of MK-0524A 2g. MK 0524A will produce less flushing that ER-niacin as measured by maximum Global Flushing Severity Score (GFSS) categorised into none/mild, moderate, severe, extreme during the first 7 days following a 5-day holiday.
Critère d'inclusion
- Hypercholesterolemia